August 2021- Scilex Holding Company, which is a subsidiary of Sorrento Therapeutics, Inc., announced that ZTlido, 1.8%, a lidocaine topical system, has been added to multiple formularies, including two national PBMs (Pharmacy Benefit Managers), a national health plan and two regional health plans.
May 2018- Teikoku Pharma USA Inc. entered into an exclusive license agreement with Link Health Group LTD for the development and distribution of TPU’s flagship product Lidoderm in China.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?